Clinical efficacy of retroperitoneal robot-assisted laparoscopic partial nephrectomy for ventral and dorsal renal tumor
10.3969/j.issn.1009-8291.2024.07.004
- VernacularTitle:经腹膜后途径机器人辅助腹腔镜下肾部分切除术治疗腹侧和背侧肾肿瘤的疗效分析
- Author:
Haonan CHEN
1
;
Xiao YANG
1
;
Peikun LIU
1
;
Lingkai CAI
1
;
Juntao ZHUANG
1
;
Qikai WU
1
;
Qiang CAO
1
;
Pengchao LI
1
;
Qiang LYU
1
Author Information
1. Department of Urology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing 210029, China
- Publication Type:Journal Article
- Keywords:
renal tumor;
retroperitoneal;
robotics;
partial nephrectomy;
ventral renal tumor;
dorsal renal tumor
- From:
Journal of Modern Urology
2024;29(7):581-585
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To compare the efficacy of retroperitoneal robot-assisted laparoscopic partial nephrectomy (RALPN) in the treatment of ventral and dorsal renal tumor. 【Methods】 The clinical data of 131 patients with renal tumor who underwent retroperitoneal RALPN at our hospital during Jan.2021 and Feb.2024 were retrospectively analyzed.The patients were divided into the ventral renal tumor group (n=35) and dorsal renal tumor group (n=96) according to preoperative images.Perioperative outcomes and prognosis were compared between the two groups. 【Results】 All 131 surgeries were successfully completed without conversion to open surgery or abdominal organ injury.There were no significant differences in warm ischemia time \[median (interquartile range, IQR):20(16.75) min vs. 22(IQR:15.25) min\], operation time\[57.0(IQR:29.5) min vs. 58.5(IQR:39.75) min\], estimated intraoperative blood loss \[50(IQR:80) mL vs. 50(IQR:80) mL\], proportion of patients with intraoperative blood transfusion (0 vs. 2.1%), proportion of patients using four arms during operation (42.9% vs. 37.5%), postoperative reduction of hemoglobin (Hb)\[(-12.9±9.0)g/L vs. (-11.5±9.4) g/L\], reduction of estimated glomerular filtration rate (eGFR)\[(-3.8±12.4 ) mL/min vs. (-7.0±13.6) mL/min\], postoperative hospital stay \[4(IQR: 0) d vs.4(IQR: 2) d\], and proportion of meeting "Trifecta" criteria (94.3% vs. 86.5%, P>0.05).During the median follow-up of 9.8(5.5, 24.0) months, no death occurred, and no recurrence or metastasis were observed except that bone metastasis occurred in 1 patient in the dorsal renal tumor group. 【Conclusion】 Both ventral and dorsal renal tumors can be treated with retroperitoneal RALPN, and the surgical outcomes of both are comparable.
